huIL18R1/huIL18RAP Mouse
제품명
huIL18R1/huIL18RAP Mouse
제품 ID
C002016
품종 계통
C57BL/6NCya-Il18r1tm1(hIL18R1)Il18raptm1(hIL18RAP)/Cya
Backgroud
C57BL/6NCya
상태
이 마우스 계통을 논문에서 사용할 경우, “huIL18R1/huIL18RAP Mouse (카탈로그 번호 C002016)은 Cyagen에서 구입하였습니다.”라고 명시해 주시기 바랍니다.
구매 가능한 제품 종류
연령
Genotype
성별
수량
유전자 별칭
ACPL, CD218b, IL-1R7, IL18RB, CDw218b, IL-1R-7, IL-18RAcP, IL-1RAcPL, IL-18Rbeta, IL-18R-beta, CD218a, IL18RA, IL1RRP, CDw218a, IL-1Rrp, IL-18Ralpha, IL18Ralpha2, IL-18R-alpha
염색체
Chr 2, Chr 2
MGI ID
Datasheet
품종 계통 설명
IL-18 is an important pro-inflammatory cytokine that binds to its receptor complex (IL-18Rα encoded by IL18R1 and IL-18Rβ encoded by IL18RAP), activating downstream MyD88/NF-κB and MAPK signaling pathways and playing key regulatory roles in innate and adaptive immunity [1]. Abnormal activation of the human IL-18/IL-18R signaling pathway is closely associated with various inflammatory diseases, including inflammatory bowel disease (IBD), rheumatoid arthritis, psoriasis, metabolic inflammation, and regulation of the tumor immune microenvironment [2].
The huIL18R1/huIL18RAP humanized mouse model was generated using gene editing technology, in which the mouse Il18r1 gene region from exon 1 to the downstream region of exon 13 of Il18rap was replaced with the corresponding human IL18R1 gene region from exon 1 to the downstream region of exon 10 of IL18RAP, enabling the expression of the human IL-18Rα/IL-18Rβ receptor complex. This model can be used to mimic the functional roles of human IL-18/IL-18R signaling in inflammatory responses. Its applications mainly include mechanistic studies of inflammatory bowel disease (IBD), rheumatoid arthritis, psoriasis and skin inflammation, as well as metabolic disease-associated inflammation. In addition, this model can be used for exploring cancer immunotherapy strategies and evaluating the potential effects of various therapeutic approaches targeting the IL-18/IL-18R pathway in regulating intestinal inflammation, joint inflammation, skin inflammation, metabolic inflammation, and the tumor microenvironment.
Reference
Zhao Y, Tang Y, Zhu X, Hou Y, Li H, Ciccia F, Zou H, Lu L. The Roles of Interleukin-18 in Inflammation and Autoimmune Disease. Clin Rev Allergy Immunol. 2026 Mar 16;69(1):17.
Zhang J, Bao L, Li X, Li J, Cui J, Qiao L, He X, Zhang M, Lu J, Zhang X, Dong J, Tao G, Bai T, Tian YP, Zhao P, Tuo Y. Mechanistic roles of interleukin‑18 in colonic immunity across infection, inflammatory bowel disease, and colorectal cancer (Review). Int J Mol Med. 2026 Jun;57(6):163.
변형 전략
The sequence from exon 1 of the mouse Il18r1 gene to the downstream of exon 13 of the Il18rap gene was replaced with the sequence from exon 1 of the human IL18R1 gene to the downstream of exon 10 of the IL18RAP gene. Since the replaced human genomic fragment contains the SDR42E1P5 pseudogene and MIR4772 microRNA gene, these human genomic elements were also introduced into the mouse genome as part of the humanized region.
Figure 1. Diagram of the gene editing strategy for the generation of huIL18R1/huIL18RAP mice.
응용 분야
Inflammatory Bowel Disease (IBD) Mechanism Research: Used to investigate the pathogenic mechanisms by which human IL-18R signaling drives intestinal inflammation, epithelial barrier disruption, and Th1/Th17 immune responses in Crohn’s disease and ulcerative colitis;
Rheumatoid Arthritis Therapeutic Evaluation: Used to assess the inhibitory effects of neutralizing antibodies targeting human IL-18 or IL-18R, as well as recombinant IL-18 binding protein (IL-18BP), on joint inflammation and bone erosion;
Psoriasis and Skin Inflammation Research: Used to study the role of human IL-18R signaling in promoting keratinocyte activation and neutrophil infiltration in psoriasis-like dermatitis;
Inflammatory Research in Metabolic Diseases: Used to explore the mechanisms by which the human IL-18/IL-18R pathway drives macrophage activation and insulin resistance in obesity, type 2 diabetes (T2D), and metabolic dysfunction-associated steatohepatitis (MASH);
Tumor Immunotherapy Validation: Used to evaluate the therapeutic potential of IL-18R agonists or antagonists in modulating the tumor microenvironment and enhancing NK cell and T cell anti-tumor activity.
문의하기
맞춤형 동물 모델 관련 상담을 위해 Cyagen 전문가와 연락해 보세요. 아래 양식을 작성하여 상담을 시작하거나 견적을 요청하시기 바랍니다.
Cyagen은 고객님의 개인정보를 소중히 여깁니다. 최신 제품, 서비스 및 인사이트를 안내드리고자 합니다. 고객님의 수신 설정은 다음과 같습니다:
해당 커뮤니케이션은 언제든지 수신 거부하실 수 있습니다. 수신 거부 방법 및 데이터 보호에 대한 자세한 내용은 개인정보처리방침을 참고해 주시기 바랍니다.
아래 버튼을 클릭함으로써, 요청하신 콘텐츠 제공을 위해 본 양식을 통해 제출된 개인정보를 Cyagen이 저장 및 처리하는 데 동의하게 됩니다.